Supporting this, SCCs, in the absence of impaired cognitive performance, have been related to the presence of Alzheimer’s disease (AD) biomarkers such as amyloid plaques in the brain and tau proteins found in cerebral spinal fluid [3, 4]. Here, MAPT is linked to Alzheimer disease.